Connect with us

News

Over 2,000 Patients Benefited From Plasma Therapy, Saved My Life Too: Delhi Health Minister

A randomised study led by the Indian Council of Medical Research, on 464 patients in 39 hospitals across 14 states and UTs has shown that plasma therapy does not reduce mortality or prevent progression of COVID-19 from moderate to severe

Over 2,000 Patients Benefited From Plasma Therapy, Saved My Life Too: Delhi Health Minister
Highlights
  • Delhi health minister contracted COVID-19 in June
  • Centre may remove plasma therapy from COVID-19 treatment protocol
  • The COVID-19 positivity rate in Delhi is at 6.32 per cent

New Delhi: Delhi Health Minister Satyendar Jain on Wednesday asserted that over 2,000 COVID-19 patients in Delhi have benefitted from plasma therapy which also saved his life, a day after a top ICMR (Indian Council of Medical Research) official indicated that the Centre was considering removing it from the clinical management protocol. At a press conference, Mr. Jain also said these patients received convalescent plasma through the dedicated plasma banks of the city government, besides other people getting it directly from donors.

Also Read: Doctors In Delhi See Jump In Breathing Issues Amid COVID-19, Pollution

The first plasma bank was opened on July 2 by Chief Minster Arvind Kejriwal at the state-run Institute of Liver and Biliary Science (ILBS) in south Delhi. After that another bank was opened at LNJP Hospital, a dedicated coronavirus facility.

We have been doing it (plasma therapy) trials after getting due permission. The ICMR-AIIMS study has not shown much breakthrough. But people are getting benefitted from it here, and over 2,000 have benefitted by receiving plasma from the dedicated bank only, Mr. Jain said, when asked about the Centre considering removing it from COVID-19 clinical management protocol.

The Delhi health minister, himself a COVID-19 survivor, asserted that “this has helped save my life too”. The health minister had tested positive for COVID-19 in June and was hospitalised. He was later administered plasma therapy at a leading private hospital here, following which he had recovered and later also urged others to donate plasma.

Even America has acknowledged its benefit. And, research is going on it world over. Delhi in a way is a pioneer in it and plasma therapy benefits have been seen. You should go and ask family members of those patients who were administered the plasma therapy, he said.

The Centre is considering to remove convalescent plasma therapy from the national clinical management protocol for COVID-19, a top ICMR official had said on Tuesday. Presently, the use of off-label convalescent plasma for treating COVID-19 patients in the moderate stage of the illness is allowed under “investigational therapies”.

Also Read: Ambulance Driver Who Ferried Hundreds Of COVID-19 Patients Succumbs To Virus In Delhi

However, a randomised controlled trial led by the Indian Council of Medical Research (ICMR), on 464 patients in 39 hospitals in 25 districts across 14 states and union territories has shown that plasma therapy does not reduce mortality or prevent progression of COVID-19 from moderate to severe. At a press conference on Tuesday, ICMR Director General Balaram Bhargava said,

We have had discussions in the national taskforce and we are in discussion with the joint monitoring group that this (convalescent plasma therapy) may be deleted from the national guidelines. The discussion is ongoing and more or less we are reaching towards that.

The national capital recorded 41 COVID-19 fatalities on Tuesday, taking the death toll to 6,081, while 3,579 fresh cases took the infection tally to over 3.36 lakh. Mr. Jain said the positivity rate as on Tuesday stood at 6.32 per cent with death rate of 1.13 per cent, based on data of the last 10 days.

The positivity rate earlier was 8.5-10 per cent, so it seems it has stabilised, compared to the peak that was. And we are closely watching it, the trend should be downward now gradually, he told reporters.

On the number of beds for patients, Jain said, only 33 per cent of these are occupied.

Also Read: Delhi May Witness Surge Of 15,000 COVID Cases Per Day In Winters: Centre

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Highlights Of The 12-Hour Telethon

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पड़े

Folk Music For A Swasth India

RajasthanDay” src=